Cargando…

Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer

BACKGROUND: EphrinA (EFNA) are Eph receptor ligands that regulate various disease processes. Nonetheless, the expression characteristics of EFNAs in pan-cancer, their relationship with tumor immune microenvironment, and prognostic value landscape remain unknown. METHODS: A comprehensive landscape of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Zonglin, Feng, Xiao, Cui, Yuqing, Wang, Lei, Gan, Junqing, Zhao, Yanbin, Meng, Qingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364540/ https://www.ncbi.nlm.nih.gov/pubmed/35945523 http://dx.doi.org/10.1186/s12885-022-09951-0

Ejemplares similares

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2021)

Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin
por: González-Reymúndez, Agustín, et al.
Publicado: (2020)

Multi-Omics Analysis of GNL3L Expression, Prognosis, and Immune Value in Pan-Cancer
por: Liu, Pei, et al.
Publicado: (2022)

Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis
por: Chen, Xingyu, et al.
Publicado: (2021)

Pan‐cancer analyses reveal multi‐omic signatures and clinical implementations of the forkhead‐box gene family
por: Bi, Xiaoman, et al.
Publicado: (2023)

Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
por: Li, Baihui, et al.
Publicado: (2020)

EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma
por: Deng, Mingming, et al.
Publicado: (2021)

EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance
por: Chu, Ling-Yu, et al.
Publicado: (2022)

Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers
por: Gong, Lian, et al.
Publicado: (2023)

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD
por: Zhang, Yuwei, et al.
Publicado: (2020)

Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy
por: Liang, Zheng, et al.
Publicado: (2021)

TBX3 and EFNA4 Variant in a Family with Ulnar-Mammary Syndrome and Sagittal Craniosynostosis
por: Tung, Moon Ley, et al.
Publicado: (2022)

Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data
por: Shen, Chong, et al.
Publicado: (2023)

Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals
por: Lou, Yuqing, et al.
Publicado: (2022)

Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
por: Zhao, Xiangyu, et al.
Publicado: (2022)

Pan-cancer analyses reveal multi-omics and clinical characteristics of RIO kinase 2 in cancer
por: Li, Kexin, et al.
Publicado: (2022)

An integrated multi-omics analysis of topoisomerase family in pan-cancer: Friend or foe?
por: Zhou, Xin, et al.
Publicado: (2022)

BnaOmics: A comprehensive platform combining pan-genome and multi-omics data from Brassica napus
por: Cui, Xiaobo, et al.
Publicado: (2023)

Visual Maps Development: Reconsidering the Role of Retinal Efnas and Basic Principle of Map Alignment
por: Savier, Elise, et al.
Publicado: (2018)

Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery
por: Li, Yuming, et al.
Publicado: (2021)

Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2022)

Multi-omics of the esophageal microenvironment identifies signatures associated with progression of Barrett’s esophagus
por: Deshpande, Nandan P., et al.
Publicado: (2021)

Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
por: Lai, Ming-Wei, et al.
Publicado: (2022)

Multi-omic network signatures of disease
por: Gibbs, David L., et al.
Publicado: (2014)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma
por: Zhang, Yiming, et al.
Publicado: (2023)

EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma
por: Hao, Yong-Ping, et al.
Publicado: (2021)

Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
por: Li, Hailong, et al.
Publicado: (2022)

A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration
por: Du, Kunpeng, et al.
Publicado: (2022)

The multi-omics analysis identifies a novel cuproptosis-anoikis-related gene signature in prognosis and immune infiltration characterization of lung adenocarcinoma
por: Jiang, Guanyu, et al.
Publicado: (2023)

The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance
por: Xie, Jindong, et al.
Publicado: (2022)

A Multi-Cohort and Multi-Omics Meta-Analysis Framework to Identify Network-Based Gene Signatures
por: Shafi, Adib, et al.
Publicado: (2019)

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019)

Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal Melanoma
por: Mo, Qianxing, et al.
Publicado: (2021)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)

Identify Function of WASL in Prognosis of Cervical Cancer Based on Omics Data
por: Hou, Jinxuan, et al.
Publicado: (2021)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2
por: Yuan, Weidong, et al.
Publicado: (2022)

Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer
por: Fan, Yeye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9d88bv84gqipk67a6dvi5kd4og